Gastrointestinal Manifestations in Patients with Systemic Lupus Erythematosus.
Samar O AlharbiPublished in: Open access rheumatology : research and reviews (2022)
Systemic lupus erythematosus (SLE) is an autoimmune disorder of unknown etiology. Women of childbearing age are affected approximately nine times more often than men. Its presentation and course are highly variable, ranging from mild to fulminant systemic disease. Any organ can be affected by SLE. Although less common than in other systems, such as the skin, joints, and kidneys, 40%-60% of SLE patients have gastrointestinal (GI) involvement. SLE can affect any part of the GI tract, from the mouth to the anus. GI manifestations can be caused by SLE, medication-related side effects, or non-SLE causes including infection. This article reviews the most common types of GI involvement associated with SLE.
Keyphrases
- systemic lupus erythematosus
- disease activity
- end stage renal disease
- rheumatoid arthritis
- healthcare
- chronic kidney disease
- newly diagnosed
- multiple sclerosis
- polycystic ovary syndrome
- type diabetes
- emergency department
- systematic review
- prognostic factors
- drug induced
- adipose tissue
- pregnant women
- peritoneal dialysis
- insulin resistance
- cervical cancer screening